These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2345066)

  • 1. A phase II study of mitoxantrone in advanced squamous cell cancer of the head and neck.
    Wheeler H; Woods RL; Page J; Levi J
    Invest New Drugs; 1990 Feb; 8(1):109-11. PubMed ID: 2345066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of mitoxantrone in head and neck carcinoma.
    Sridhar KS; Hussein AM; Benedetto P; Waldman SM; Feun LG; Savaraj N; Richman SP; Ardalan B; Desai P
    Am J Clin Oncol; 1991 Aug; 14(4):298-304. PubMed ID: 1650529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Thurnher D; Kornfehl J; Burian M; Gedlicka C; Selzer E; Quint C; Neuchrist C; Kornek GV
    Anticancer Drugs; 2001 Mar; 12(3):205-8. PubMed ID: 11290867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of high-dose mitoxantrone in the treatment of recurrent squamous cell carcinoma of the head and neck.
    Stewart DJ; Cripps C; Maroun JA
    Am J Clin Oncol; 1987 Aug; 10(4):307-9. PubMed ID: 3618542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of mitoxantrone in advanced squamous cell carcinoma of the head and neck. A Southeastern Cancer Study Group trial.
    Williams SD; Birch R; Velez-Garcia E; Gams R
    Invest New Drugs; 1985; 3(3):311-3. PubMed ID: 4066226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Southwest Oncology Group study of Mitoxantrone for treatment of patients with advanced squamous cell carcinoma of the head and neck.
    Mattox DE; Clark GM; Balcerzak SP; O'Bryan RM; Oishi N; Stuckey WJ
    Invest New Drugs; 1984; 2(4):405-7. PubMed ID: 6511243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Southwest Oncology Group study of mitoxantrone for treatment of patients with advanced adenoid cystic carcinoma of the head and neck.
    Mattox DE; Von Hoff DD; Balcerzak SP
    Invest New Drugs; 1990 Feb; 8(1):105-7. PubMed ID: 2160919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck. EORTC Head and Neck Cancer Cooperative Group.
    Verweij J; de Mulder PH; de Graeff A; Vermorken JB; Wildiers J; Kerger J; Schornagel J; Cognetti F; Kirkpatrick A; Sahmoud T; Lefebvre JL
    Ann Oncol; 1996 Oct; 7(8):867-9. PubMed ID: 8922205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of intravenous melphalan (NSC-8806) in the treatment of patients with advanced squamous carcinoma of the head and neck.
    Kies MS; Grinblatt D; Runge-Morris M; Blough R; Watkins A; Taylor S
    Invest New Drugs; 1994; 12(1):45-7. PubMed ID: 7960605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An EORTC phase II study of mitoxantrone in solid tumors and lymphomas.
    De Jager R; Cappelaere P; Armand JP; Keiling R; Fargeot P; Bastit P; van Glabbeke M; Renard J; Earl H; Rubens R
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1369-75. PubMed ID: 6542006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of vindesine in patients with squamous cell cancer of the head and neck.
    Sledge GW; Clark GM; Griffin C; Mattox DE; Von Hoff DD
    Am J Clin Oncol; 1984 Jun; 7(3):209-11. PubMed ID: 6731343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
    Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
    J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: a report from the UCL-Oncology Group, Belgium.
    Grégoire V; Beauduin M; Humblet Y; Hamoir M; Longueville J; Majois F; Remacle FM; Rousseau F; Salamon E; Wambersie A
    J Clin Oncol; 1991 Aug; 9(8):1385-92. PubMed ID: 2072142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Gedlicka C; Formanek M; Selzer E; Burian M; Kornfehl J; Fiebiger W; Cartellieri M; Marks B; Kornek GV
    Oncology; 2002; 63(2):145-50. PubMed ID: 12239449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternating cisplatinum and VAC ineffective in end stage squamous cell carcinoma of the head and neck.
    Siodlak MZ; Stell PM; Wilson JA; Green JA; Allison RS; Adler D; Squadrelli-Saraceno M
    J Laryngol Otol; 1990 Aug; 104(8):631-3. PubMed ID: 2230560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck.
    Haffty BG; Son YH; Wilson LD; Papac R; Fischer D; Rockwell S; Sartorelli AC; Ross D; Sasaki CT; Fischer JJ
    Radiat Oncol Investig; 1997; 5(5):235-45. PubMed ID: 9372546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of cisplatin, 5-fluorouracil and folinic acid using a weekly 24-h infusion schedule for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
    Riva C; Lavieille JP; Schmerber S; Cuisnie O; Reyt E
    Int J Oncol; 2000 Sep; 17(3):543-9. PubMed ID: 10938396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of tallysomycin S10b in patients with advanced head and neck cancer.
    Nicaise C; Hong WK; Dimery W; Usakewicz J; Rozencweig M; Krakoff I
    Invest New Drugs; 1990 Aug; 8(3):325-8. PubMed ID: 1703132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy for unresectable recurrent or metastatic squamous cell carcinomas of the head and neck].
    Nishino H; Fujisawa Y; Kanazawa T; Ishikawa K; Miyata M; Ichimura K; Abe K; Tanaka H
    Nihon Jibiinkoka Gakkai Kaiho; 2000 Sep; 103(9):963-9. PubMed ID: 11070972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of doxifluridine in advanced squamous cell carcinoma of the head and neck.
    Abele R; Kaplan E; Grossenbacher R; Schmid HJ; Cavalli F
    Eur J Cancer Clin Oncol; 1984 Mar; 20(3):333-6. PubMed ID: 6231185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.